Русский
Bisoprolol In Therapy Of Arterial Hypertension And Ischemic Heart Disease
A.A. Kirichenko
Bisoprolol in therapy of arterial hypertension and ischemic heart disease
Beta-blockers (BB) are associated with decreasing of mortality and other cardiovascular endpoints in patients with arterial hypertension (AH), acute and chronic forms of ischemic heart disease (IHD). BB are especially effective in decreasing of fatal ventricular arrhythmias in patients with high risk of sudden cardiac death. Selective beta1-BB without intrinsic sympathomimetic activity bisoprolol is characterized by high bioavailability, long elimination half-life, well-balanced clearance. Clinical studies demonstrated positive effect of bicoprolol on cardiovascular morbidity and mortality in patients with AH and IHD.
Beta-blockers (BB) are associated with decreasing of mortality and other cardiovascular endpoints in patients with arterial hypertension (AH), acute and chronic forms of ischemic heart disease (IHD). BB are especially effective in decreasing of fatal ventricular arrhythmias in patients with high risk of sudden cardiac death. Selective beta1-BB without intrinsic sympathomimetic activity bisoprolol is characterized by high bioavailability, long elimination half-life, well-balanced clearance. Clinical studies demonstrated positive effect of bicoprolol on cardiovascular morbidity and mortality in patients with AH and IHD.
Similar Articles
